HMCIB SPAC 3
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more
Market Cap & Net Worth: HMCIB SPAC 3 (226340)
HMCIB SPAC 3 (KQ:226340) has a market capitalization of $41.77 Million (₩61.17 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25104 globally and #1518 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HMCIB SPAC 3's stock price ₩1458.00 by its total outstanding shares 41952400 (41.95 Million).
HMCIB SPAC 3 Market Cap History: 2015 to 2025
HMCIB SPAC 3's market capitalization history from 2015 to 2025. Data shows change from $56.73 Million to $41.77 Million (-3.51% CAGR).
Index Memberships
HMCIB SPAC 3 is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.01% | #777 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.01% | #777 of 1384 |
Weight: HMCIB SPAC 3's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HMCIB SPAC 3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HMCIB SPAC 3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HMCIB SPAC 3's market cap is 0.00 times its annual revenue
0.11x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $57.16 Million | $23.63 Billion | $116.97 Million | 0.00x | 0.49x |
| 2018 | $57.45 Million | $29.23 Billion | $313.44 Million | 0.00x | 0.18x |
| 2019 | $109.16 Million | $47.02 Billion | $5.03 Billion | 0.00x | 0.02x |
| 2020 | $67.19 Million | $36.05 Billion | -$1.92 Billion | 0.00x | N/A |
| 2021 | $63.75 Million | $53.81 Billion | -$3.98 Billion | 0.00x | N/A |
| 2022 | $47.56 Million | $60.72 Billion | $2.00 Billion | 0.00x | 0.02x |
| 2023 | $64.61 Million | $72.91 Billion | -$724.79 Million | 0.00x | N/A |
Competitor Companies of 226340 by Market Capitalization
Companies near HMCIB SPAC 3 in the global market cap rankings as of March 18, 2026.
Key companies related to HMCIB SPAC 3 by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
HMCIB SPAC 3 Historical Marketcap From 2015 to 2025
Between 2015 and today, HMCIB SPAC 3's market cap moved from $56.73 Million to $ 41.77 Million, with a yearly change of -3.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩41.77 Million | +6.42% |
| 2024 | ₩39.25 Million | -39.25% |
| 2023 | ₩64.61 Million | +35.84% |
| 2022 | ₩47.56 Million | -25.39% |
| 2021 | ₩63.75 Million | -5.12% |
| 2020 | ₩67.19 Million | -38.45% |
| 2019 | ₩109.16 Million | +90.02% |
| 2018 | ₩57.45 Million | +0.50% |
| 2017 | ₩57.16 Million | +0.50% |
| 2016 | ₩56.87 Million | +0.25% |
| 2015 | ₩56.73 Million | -- |
End of Day Market Cap According to Different Sources
On Jan 7th, 2026 the market cap of HMCIB SPAC 3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $41.77 Million USD |
| MoneyControl | $41.77 Million USD |
| MarketWatch | $41.77 Million USD |
| marketcap.company | $41.77 Million USD |
| Reuters | $41.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.